154 related articles for article (PubMed ID: 31607617)
1. De Novo Cancer Incidence and Prognosis After Kidney Transplantation: A Single Center Analysis.
Gioco R; Corona D; Agodi A; Privitera F; Barchitta M; Giaquinta A; Alba I; D'Errico S; Pinto F; De Pasquale C; Pistorio ML; Veroux P; Veroux M
Transplant Proc; 2019 Nov; 51(9):2927-2930. PubMed ID: 31607617
[TBL] [Abstract][Full Text] [Related]
2. De Novo Urologic Malignancies in Renal Transplant Recipients.
Antunes H; Tavares-da-Silva E; Oliveira R; Carvalho J; Parada B; Bastos C; Figueiredo A
Transplant Proc; 2018 Jun; 50(5):1348-1354. PubMed ID: 29753463
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Survival of Cancer After Pancreas-Kidney Transplantation.
Pendón-Ruiz de Mier MV; Agüera ML; Navarro MD; Rodriguez-Benot A; Aljama P
Transplant Proc; 2018 Mar; 50(2):669-672. PubMed ID: 29579884
[TBL] [Abstract][Full Text] [Related]
4. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
5. De Novo Malignant Neoplasms in Renal Transplant Patients.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
[TBL] [Abstract][Full Text] [Related]
6. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Long-Term Prognosis of Cancer After Kidney Transplantation.
Pendón-Ruiz de Mier V; Navarro Cabello MD; Martínez Vaquera S; Lopez-Andreu M; Aguera Morales ML; Rodriguez-Benot A; Aljama Garcia P
Transplant Proc; 2015 Nov; 47(9):2618-21. PubMed ID: 26680052
[TBL] [Abstract][Full Text] [Related]
8. De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years.
Zavos G; Moris D; Kostakis ID; Vernadakis S; Bokos J; Zavvos V; Lionaki S; Boletis J
Exp Clin Transplant; 2015 Aug; 13(4):313-8. PubMed ID: 26295181
[TBL] [Abstract][Full Text] [Related]
9. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
10. [Early de novo neoplasia after renal transplantation].
Veroux P; Veroux M; Puliatti C; Amodeo C; Macarone M; Cappello D; Caglià P
Tumori; 2003; 89(4 Suppl):301-4. PubMed ID: 12903627
[TBL] [Abstract][Full Text] [Related]
11. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
12. Malignancy in renal transplant recipients: a single-center experience in Thailand.
Ruangkanchanasetr P; Lauhawatana B; Leawseng S; Kitpanich S; Lumpaopong A; Thirakhupt P
J Med Assoc Thai; 2012 May; 95 Suppl 5():S12-6. PubMed ID: 22934439
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of De Novo Malignancy After Liver Transplant: A Single-Center Study.
Kim S; Rovgaliyev B; Lee JM; Lee KW; Hong SK; Cho JH; Yoon KC; Yi NJ; Suh KS
Transplant Proc; 2021; 53(1):200-206. PubMed ID: 32409224
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan.
Chiu HF; Chung MC; Chung CJ; Yu TM; Shu KH; Wu MJ
Transplant Proc; 2016 Apr; 48(3):918-20. PubMed ID: 27234767
[TBL] [Abstract][Full Text] [Related]
15. Malignancy after renal transplantation: a single-center experience.
Vrotniakaite K; Jaceviciute R; Rudminiene I; Laucyte-Cibulskiene A; Rainiene T; Jankevicius F; Zelvys A; Miglinas M
Ann Transplant; 2014 Sep; 19():456-63. PubMed ID: 25223375
[TBL] [Abstract][Full Text] [Related]
16. De novo malignancy in heart transplant recipients: A single center experience in Japan.
Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
[TBL] [Abstract][Full Text] [Related]
17. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
18. De-novo malignancies after kidney transplantation: A long-term observational study.
Fröhlich FA; Halleck F; Lehner L; Schrezenmeier EV; Naik M; Schmidt D; Khadzhynov D; Kast K; Budde K; Staeck O
PLoS One; 2020; 15(11):e0242805. PubMed ID: 33253202
[TBL] [Abstract][Full Text] [Related]
19. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
[TBL] [Abstract][Full Text] [Related]
20. Malignancy following renal transplantation.
Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
